New EU active substance approval decisions

Apply for product authorisation by the deadline to keep your products on the NI market.

Following evaluation under the EU Biocidal Products Regulation (EU BPR), a decision has been taken to approve the following active substance/product type combinations. This will affect NI:

1 February 2027

• Peracetic acid generated from 1,3-diacetyloxypropan-2-yl acetate and hydrogen peroxide (CAS N/A EC N/A) in product type 2

• 2-methyl-2H-isothiazol-3-one (MIT) (CAS 2682-20-4 EC 220-239-6) in product type 6

Action for biocidal product suppliers

If you supply biocidal products containing these active substances in the relevant product types, you must apply for EU BPR product authorisation by 1 February 2027 to keep them on the NI market.

New products must not be supplied in NI until product authorisation is granted.

Action for active substance suppliers

If you supply these active substances for use in biocidal products of the relevant product types, you may need to apply for technical equivalence. If you haven’t demonstrated technical equivalence for your manufacturing source, EU BPR product authorisation cannot be granted for biocidal products containing your active substance.